Patent details

EP2089356 Title: SALT OF ALISKIREN WITH OROTIC ACID

Basic Information

Publication number:
EP2089356
PCT Application Number:
PCT/EP/2007/009644
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078196540
PCT Publication Number:
WO/2008/055669
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SALT OF ALISKIREN WITH OROTIC ACID
French Title of Invention:
SEL D'ALISKIRÈNE AVEC DE L'ACIDE OROTIQUE
German Title of Invention:
SALZ VON ALISKIREN MIT OROTSÄURE
SPC Number:

Dates

Filing date:
07/11/2007
Grant date:
25/04/2012
EP Publication Date:
25/04/2012
PCT Publication Date:
15/05/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/08/2009
EP B1 Publication Date:
25/04/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/11/2012
Expiration date:
07/11/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/11/2007
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
REBER Jean-Louis
Address:
France (FR)

2

Name:
STOWASSER Frank
Address:
Germany (DE)

Priority

Priority Number:
06123758
Priority Date:
09/11/2006
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07C 237/22;
Filing date Document type Number of pages